Affinity NMR

Because binding ligands are directly detected and identified, the diffusion-based NMR method and NOE pumping approach promise to greatly simplify deconvolution in drug screening. An additional advantage of these techniques is that low-affinity ligands, which might be missed by high-throughput screen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Analytical chemistry (Washington) 1999-10, Vol.71 (19), p.669A-675A
Hauptverfasser: AIDI CHEN, SHAPIRO, M. J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 675A
container_issue 19
container_start_page 669A
container_title Analytical chemistry (Washington)
container_volume 71
creator AIDI CHEN
SHAPIRO, M. J
description Because binding ligands are directly detected and identified, the diffusion-based NMR method and NOE pumping approach promise to greatly simplify deconvolution in drug screening. An additional advantage of these techniques is that low-affinity ligands, which might be missed by high-throughput screening, can be detected and could serve as synthetic precursors for higher affinity ligands. The biggest challenge to NMR methodology lies in its sensitivity. Compared with other techniques, such as MS (25), NMR methods for screening mixtures are limited by their relative insensitivity. Because of issues such as solubility, stability, and mass limitation, it is not in general judicious to simply increase the concentration of the mixture. Improvements in hardware and software are necessary to extend the applicability of the affinity NMR method to the screening of larger and more complex mixtures. A boost in sensitivity and screening capacity of NMR technique is possible by the implementation of microcoil (26) and flow probe techniques. An upsurge in the capabilities of mixture analysis could be achieved with a combination of independent and complementary techniques (e.g., HPLC, MS) (27). As a unique, nondestructive, and versatile tool, NMR will continue on its fast track of development in the support of drug discovery.
doi_str_mv 10.1021/ac9907179
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_70827731</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70827731</sourcerecordid><originalsourceid>FETCH-LOGICAL-p263t-2c6b8dd4f88f8dc179fc61442636722efdcd96e2f39dbff766f15e082a1e7af3</originalsourceid><addsrcrecordid>eNpdz01LAzEQBuAgiq2tB_-AiIi31ZlkO0mOpfgFVUF6X9IkA1t2t3XTPfTfu-KK4GkO78PMO0JcINwhSLx33lrQqO2RGONMQkbGyGMxBgCVSQ0wEmcpbQAQAelUjBBmqFHRWEznzGVT7g9Xb68fU3HCrkrxfJgTsXp8WC2es-X708tivsx2ktQ-k57WJoScjWETfH-XPWGe9yFpKSMHHyxFycqGNbMmYpxFMNJh1I7VRNz-rN21288upn1Rl8nHqnJN3Hap0D3VWmEPr__BzbZrm75aIVGbnEh-o8sBdes6hmLXlrVrD8Xvjz24GYBL3lXcusaX6c9ZTcpq9QVppluP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217846621</pqid></control><display><type>article</type><title>Affinity NMR</title><source>MEDLINE</source><source>ACS Publications</source><creator>AIDI CHEN ; SHAPIRO, M. J</creator><creatorcontrib>AIDI CHEN ; SHAPIRO, M. J</creatorcontrib><description>Because binding ligands are directly detected and identified, the diffusion-based NMR method and NOE pumping approach promise to greatly simplify deconvolution in drug screening. An additional advantage of these techniques is that low-affinity ligands, which might be missed by high-throughput screening, can be detected and could serve as synthetic precursors for higher affinity ligands. The biggest challenge to NMR methodology lies in its sensitivity. Compared with other techniques, such as MS (25), NMR methods for screening mixtures are limited by their relative insensitivity. Because of issues such as solubility, stability, and mass limitation, it is not in general judicious to simply increase the concentration of the mixture. Improvements in hardware and software are necessary to extend the applicability of the affinity NMR method to the screening of larger and more complex mixtures. A boost in sensitivity and screening capacity of NMR technique is possible by the implementation of microcoil (26) and flow probe techniques. An upsurge in the capabilities of mixture analysis could be achieved with a combination of independent and complementary techniques (e.g., HPLC, MS) (27). As a unique, nondestructive, and versatile tool, NMR will continue on its fast track of development in the support of drug discovery.</description><identifier>ISSN: 0003-2700</identifier><identifier>EISSN: 1520-6882</identifier><identifier>DOI: 10.1021/ac9907179</identifier><identifier>PMID: 10517136</identifier><identifier>CODEN: ANCHAM</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Biological and medical sciences ; Chemistry ; Drug Evaluation, Preclinical - methods ; General pharmacology ; Image Processing, Computer-Assisted ; Ligands ; Magnetic Resonance Spectroscopy - methods ; Matrix Metalloproteinase 3 - analysis ; Matrix Metalloproteinase 3 - metabolism ; Medical sciences ; NMR ; Nuclear magnetic resonance ; Pharmacology. Drug treatments ; Physicochemical properties. Structure-activity relationships ; Receptors, Drug - metabolism ; Salicylic Acid - metabolism ; Serum Albumin - analysis ; Serum Albumin - metabolism</subject><ispartof>Analytical chemistry (Washington), 1999-10, Vol.71 (19), p.669A-675A</ispartof><rights>1999 INIST-CNRS</rights><rights>Copyright American Chemical Society Oct 1, 1999</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1976397$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10517136$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>AIDI CHEN</creatorcontrib><creatorcontrib>SHAPIRO, M. J</creatorcontrib><title>Affinity NMR</title><title>Analytical chemistry (Washington)</title><addtitle>Anal Chem</addtitle><description>Because binding ligands are directly detected and identified, the diffusion-based NMR method and NOE pumping approach promise to greatly simplify deconvolution in drug screening. An additional advantage of these techniques is that low-affinity ligands, which might be missed by high-throughput screening, can be detected and could serve as synthetic precursors for higher affinity ligands. The biggest challenge to NMR methodology lies in its sensitivity. Compared with other techniques, such as MS (25), NMR methods for screening mixtures are limited by their relative insensitivity. Because of issues such as solubility, stability, and mass limitation, it is not in general judicious to simply increase the concentration of the mixture. Improvements in hardware and software are necessary to extend the applicability of the affinity NMR method to the screening of larger and more complex mixtures. A boost in sensitivity and screening capacity of NMR technique is possible by the implementation of microcoil (26) and flow probe techniques. An upsurge in the capabilities of mixture analysis could be achieved with a combination of independent and complementary techniques (e.g., HPLC, MS) (27). As a unique, nondestructive, and versatile tool, NMR will continue on its fast track of development in the support of drug discovery.</description><subject>Biological and medical sciences</subject><subject>Chemistry</subject><subject>Drug Evaluation, Preclinical - methods</subject><subject>General pharmacology</subject><subject>Image Processing, Computer-Assisted</subject><subject>Ligands</subject><subject>Magnetic Resonance Spectroscopy - methods</subject><subject>Matrix Metalloproteinase 3 - analysis</subject><subject>Matrix Metalloproteinase 3 - metabolism</subject><subject>Medical sciences</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Pharmacology. Drug treatments</subject><subject>Physicochemical properties. Structure-activity relationships</subject><subject>Receptors, Drug - metabolism</subject><subject>Salicylic Acid - metabolism</subject><subject>Serum Albumin - analysis</subject><subject>Serum Albumin - metabolism</subject><issn>0003-2700</issn><issn>1520-6882</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdz01LAzEQBuAgiq2tB_-AiIi31ZlkO0mOpfgFVUF6X9IkA1t2t3XTPfTfu-KK4GkO78PMO0JcINwhSLx33lrQqO2RGONMQkbGyGMxBgCVSQ0wEmcpbQAQAelUjBBmqFHRWEznzGVT7g9Xb68fU3HCrkrxfJgTsXp8WC2es-X708tivsx2ktQ-k57WJoScjWETfH-XPWGe9yFpKSMHHyxFycqGNbMmYpxFMNJh1I7VRNz-rN21288upn1Rl8nHqnJN3Hap0D3VWmEPr__BzbZrm75aIVGbnEh-o8sBdes6hmLXlrVrD8Xvjz24GYBL3lXcusaX6c9ZTcpq9QVppluP</recordid><startdate>19991001</startdate><enddate>19991001</enddate><creator>AIDI CHEN</creator><creator>SHAPIRO, M. J</creator><general>American Chemical Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QF</scope><scope>7QO</scope><scope>7QQ</scope><scope>7SC</scope><scope>7SE</scope><scope>7SP</scope><scope>7SR</scope><scope>7TA</scope><scope>7TB</scope><scope>7TM</scope><scope>7U5</scope><scope>7U7</scope><scope>7U9</scope><scope>8BQ</scope><scope>8FD</scope><scope>C1K</scope><scope>F28</scope><scope>FR3</scope><scope>H8D</scope><scope>H8G</scope><scope>H94</scope><scope>JG9</scope><scope>JQ2</scope><scope>KR7</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19991001</creationdate><title>Affinity NMR</title><author>AIDI CHEN ; SHAPIRO, M. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p263t-2c6b8dd4f88f8dc179fc61442636722efdcd96e2f39dbff766f15e082a1e7af3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Biological and medical sciences</topic><topic>Chemistry</topic><topic>Drug Evaluation, Preclinical - methods</topic><topic>General pharmacology</topic><topic>Image Processing, Computer-Assisted</topic><topic>Ligands</topic><topic>Magnetic Resonance Spectroscopy - methods</topic><topic>Matrix Metalloproteinase 3 - analysis</topic><topic>Matrix Metalloproteinase 3 - metabolism</topic><topic>Medical sciences</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Pharmacology. Drug treatments</topic><topic>Physicochemical properties. Structure-activity relationships</topic><topic>Receptors, Drug - metabolism</topic><topic>Salicylic Acid - metabolism</topic><topic>Serum Albumin - analysis</topic><topic>Serum Albumin - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>AIDI CHEN</creatorcontrib><creatorcontrib>SHAPIRO, M. J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Aluminium Industry Abstracts</collection><collection>Biotechnology Research Abstracts</collection><collection>Ceramic Abstracts</collection><collection>Computer and Information Systems Abstracts</collection><collection>Corrosion Abstracts</collection><collection>Electronics &amp; Communications Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Materials Business File</collection><collection>Mechanical &amp; Transportation Engineering Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ANTE: Abstracts in New Technology &amp; Engineering</collection><collection>Engineering Research Database</collection><collection>Aerospace Database</collection><collection>Copper Technical Reference Library</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Materials Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>Civil Engineering Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts – Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Analytical chemistry (Washington)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>AIDI CHEN</au><au>SHAPIRO, M. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Affinity NMR</atitle><jtitle>Analytical chemistry (Washington)</jtitle><addtitle>Anal Chem</addtitle><date>1999-10-01</date><risdate>1999</risdate><volume>71</volume><issue>19</issue><spage>669A</spage><epage>675A</epage><pages>669A-675A</pages><issn>0003-2700</issn><eissn>1520-6882</eissn><coden>ANCHAM</coden><abstract>Because binding ligands are directly detected and identified, the diffusion-based NMR method and NOE pumping approach promise to greatly simplify deconvolution in drug screening. An additional advantage of these techniques is that low-affinity ligands, which might be missed by high-throughput screening, can be detected and could serve as synthetic precursors for higher affinity ligands. The biggest challenge to NMR methodology lies in its sensitivity. Compared with other techniques, such as MS (25), NMR methods for screening mixtures are limited by their relative insensitivity. Because of issues such as solubility, stability, and mass limitation, it is not in general judicious to simply increase the concentration of the mixture. Improvements in hardware and software are necessary to extend the applicability of the affinity NMR method to the screening of larger and more complex mixtures. A boost in sensitivity and screening capacity of NMR technique is possible by the implementation of microcoil (26) and flow probe techniques. An upsurge in the capabilities of mixture analysis could be achieved with a combination of independent and complementary techniques (e.g., HPLC, MS) (27). As a unique, nondestructive, and versatile tool, NMR will continue on its fast track of development in the support of drug discovery.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>10517136</pmid><doi>10.1021/ac9907179</doi></addata></record>
fulltext fulltext
identifier ISSN: 0003-2700
ispartof Analytical chemistry (Washington), 1999-10, Vol.71 (19), p.669A-675A
issn 0003-2700
1520-6882
language eng
recordid cdi_proquest_miscellaneous_70827731
source MEDLINE; ACS Publications
subjects Biological and medical sciences
Chemistry
Drug Evaluation, Preclinical - methods
General pharmacology
Image Processing, Computer-Assisted
Ligands
Magnetic Resonance Spectroscopy - methods
Matrix Metalloproteinase 3 - analysis
Matrix Metalloproteinase 3 - metabolism
Medical sciences
NMR
Nuclear magnetic resonance
Pharmacology. Drug treatments
Physicochemical properties. Structure-activity relationships
Receptors, Drug - metabolism
Salicylic Acid - metabolism
Serum Albumin - analysis
Serum Albumin - metabolism
title Affinity NMR
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T15%3A44%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Affinity%20NMR&rft.jtitle=Analytical%20chemistry%20(Washington)&rft.au=AIDI%20CHEN&rft.date=1999-10-01&rft.volume=71&rft.issue=19&rft.spage=669A&rft.epage=675A&rft.pages=669A-675A&rft.issn=0003-2700&rft.eissn=1520-6882&rft.coden=ANCHAM&rft_id=info:doi/10.1021/ac9907179&rft_dat=%3Cproquest_pubme%3E70827731%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=217846621&rft_id=info:pmid/10517136&rfr_iscdi=true